TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 272042

Group type: EXPERIMENTAL
Intervention: Experimental diamond discs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3M discs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rough corundum discs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Polishing paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Unfinished and sealed surfaces
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sealed surfaces and surfaces finished by the matrix alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All finishing methods
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Adaptic surfaces
Number of subjects: 20
Study: 31196137

Group type: EXPERIMENTAL
Intervention: Usual waiver care with internal facilitation of the implementation strategies
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Usual waiver care with both internal and external facilitation of the implementation strategies
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Intervention addressing individual's capabilities and home environment
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Intervention effects on primary outcomes
Number of subjects: 15000
Study: 28603306

Group type: EXPERIMENTAL
Intervention: Supportive supervision after a WHO training course for 1 year
Number of subjects: 4626

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4626
Study: 26559269

Group type: EXPERIMENTAL
Intervention: Simo Decoction (SMD) and acupuncture
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 162

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 162
Study: 22563790

Group type: EXPERIMENTAL
Intervention: Long-term psychodynamic psychotherapy
Number of subjects: 326

Group type: COMPARATOR
Intervention: Short-term psychodynamic psychotherapy
Number of subjects: 326

Group type: COMPARATOR
Intervention: Solution-focused therapy
Number of subjects: 326
Study: 21819751

Group type: EXPERIMENTAL
Intervention: 0.6% olopatadine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 22
Study: 20084974

Group type: EXPERIMENTAL
Intervention: Rabipur produced in India
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rabipur produced in Germany
Number of subjects: 0
Study: 16680285

Group type: EXPERIMENTAL
Intervention: Music therapy session with classical music for 30 minutes
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 84
Study: 15294368

Group type: EXPERIMENTAL
Intervention: 3-day clomiphene citrate (CC) regimen (50mg per day for 3 days)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 5-day clomiphene citrate (CC) regimen (50mg per day for 5 days)
Number of subjects: 59
Study: 11478142

Group type: EXPERIMENTAL
Intervention: High-dose MPA (600 mg/day) for over 8 weeks
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cyclic administrations of low-dose MPA after high-dose MPA
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MPA as adjuvant therapy after complete operations and whole pelvic irradiation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MPA in combination with chemotherapy (CAP)
Number of subjects: 14
Study: 11194002

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 46
Study: 8859724

Group type: EXPERIMENTAL
Intervention: Interferon-gamma (IFN-gamma) and interleukin-2 (IL-2) combination therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Interferon-gamma (IFN-gamma) alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Combination treatment of tumor-infiltrating lymphocytes (TIL), IL-2, and IFN-gamma
Number of subjects: 20
Study: 1995262

Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg intravenously)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Balloon distension at proximal site
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Balloon distension at distal site
Number of subjects: 10
Study: 6189074

Group type: COMPARATOR
Intervention: DVI pacing
Number of subjects: 50

Group type: COMPARATOR
Intervention: VDD/DDD pacing
Number of subjects: 50
Study: 31961420

Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation plus renal denervation
Number of subjects: 302

Group type: COMPARATOR
Intervention: Pulmonary vein isolation alone
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 302
Study: 30609099

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy for insomnia (n=106)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Attention control (n=53)
Number of subjects: 159
Study: 29543805

Group type: EXPERIMENTAL
Intervention: Insecticide-treated screening (ITS) with pyrethroid-impregnated long-lasting insecticide-treated netting material installed on external doors and windows.
Number of subjects: 844

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 844
Study: 27136744

Group type: EXPERIMENTAL
Intervention: GEMOX plus cetuximab
Number of subjects: 80

Group type: COMPARATOR
Intervention: GEMOX
Number of subjects: 80
Study: 24577747

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (sleep‐related behavior modification and progressive muscle relaxation) for 3 months
Number of subjects: 103
Study: 22168538

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg single dose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg single dose
Number of subjects: 26
Study: 20645951

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1 μg.kg(‐1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intranasal placebo (0.9% saline)
Number of subjects: 100
Study: 17685853

Group type: EXPERIMENTAL
Intervention: Aerosolized tgAAVCF (1x10^13 DNase-resistant particles), n=51
Number of subjects: 102

Group type: COMPARATOR
Intervention: Matching placebo, n=51
Number of subjects: 102
Study: 16670047

Group type: EXPERIMENTAL
Intervention: Life and death studies (LDS) program (13-week course including lectures, video appraisal, games, simulations, films, books, assignments, and group sharing)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 96
Study: 12236605

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10349190

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (25 micrograms)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (50 micrograms)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (100 micrograms)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol (200 micrograms)
Number of subjects: 9
Study: 8745497

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of glucose controlled by pump
Number of subjects: 336

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 336
Study: 2665553

Group type: EXPERIMENTAL
Intervention: Alcohol stimuli
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pepper juice stimuli
Number of subjects: 24

Group type: COMPARATOR
Intervention: Water stimuli
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alcoholic subjects
Number of subjects: 24
Study: 31228427

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 28719708

Group type: EXPERIMENTAL
Intervention: PlasmaBlade
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cold dissection
Number of subjects: 20
Study: 25735650

Group type: EXPERIMENTAL
Intervention: Multi-strategy intervention to support clubs to implement responsible alcohol management practices
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 87
Study: 23228884

Group type: EXPERIMENTAL
Intervention: Intranasal phototherapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Azelastine
Number of subjects: 77
Study: 21760549

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Emergency Cold Containment System (ECCS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ice Buckets (IB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ice Towels (IT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Shade
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Port‐a‐Cool® (FAN)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Rehab. Hood® (HOOD)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Game Ready Active Cooling Vest™ (GRV)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nike Ice Vest™ (NIV)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (SUN)
Number of subjects: 16
Study: 19390448

Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual-Controlled Ventilation (MCV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 90
Study: 16775552

Group type: EXPERIMENTAL
Intervention: 400 IU of vitamin E + 1 g of vitamin C (V; N=15)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fruit and vegetable juice powder concentrate (FV; N=16)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (P; N=17)
Number of subjects: 48
Study: 16294572

Group type: EXPERIMENTAL
Intervention: Assertive community treatment
Number of subjects: 98

Group type: COMPARATOR
Intervention: Integrated assertive community treatment
Number of subjects: 98
Study: 11524344

Group type: EXPERIMENTAL
Intervention: Metaraminol infusion (0.25 mg/min, titrated)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control Group (no bolus)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups (no significant difference)
Number of subjects: 66
Study: 9311323

Group type: EXPERIMENTAL
Intervention: Clinical-practice intervention involving a summary of completed pain scales reviewed by oncologists before evaluation.
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group without the summary of pain scales.
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Pain Management Index (PMI) measurement.
Number of subjects: 320
Study: 8513520

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 100 micrograms intraoperatively, self-administered maximum of two epidural fentanyl boluses 50 micrograms (10 micrograms.ml‐1) with a lockout period of five minutes for a maximum of two doses per hour.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Single bolus of epidural morphine 3 mg (0.5 mg.ml‐1) intraoperatively, with PCA devices filled with 0.9% NaCl.
Number of subjects: 23
Study: 3423310

Group type: EXPERIMENTAL
Intervention: Intensity controlled exercise (experimental group, n = 20)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Typical intensity exercise (control group, n = 18)
Number of subjects: 38
Study: 30138718

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) 1000 IU/day
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) 2000 IU/day
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) 4000 IU/day
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Vitamin D3 (cholecalciferol) 200 IU/day
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Short Physical Performance Battery score
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Physical activity level (assessed by accelerometry)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Frailty score
Number of subjects: 1200
Study: 28372335

Group type: EXPERIMENTAL
Intervention: Regular insulin (40 IU daily for four months)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Insulin detemir (40 IU daily for four months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 26058676

Group type: EXPERIMENTAL
Intervention: New de-prescribing intervention involving pharmacists educating patients and prescribers, with a follow-up period of 1 year.
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 450
Study: 23168371

Group type: EXPERIMENTAL
Intervention: 1 day per week training (EG1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 2 days per week training (EG2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3 days per week training (EG3)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 20556262

Group type: EXPERIMENTAL
Intervention: Immediate loading group (60 implants)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Delayed loading group (60 implants)
Number of subjects: 71
Study: 18480688

Group type: EXPERIMENTAL
Intervention: Tiagabine (4, 8, or 12 mg/d in fixed-dose study; 4-16 mg/d in flexible-dose trials)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16878723

Group type: EXPERIMENTAL
Intervention: β-blockers therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 12509593

Group type: EXPERIMENTAL
Intervention: Cod liver oil (10 mL containing 1183 mg DHA)
Number of subjects: 590

Group type: COMPARATOR
Intervention: Corn oil (10 mL containing 4747 mg linoleic acid)
Number of subjects: 590
Study: 11094013

Group type: EXPERIMENTAL
Intervention: Propofol (1 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental (2 mg/kg)
Number of subjects: 40
Study: 8891641

Group type: EXPERIMENTAL
Intervention: Magnetic cortical stimulation
Number of subjects: 6
Study: 1893647

Group type: EXPERIMENTAL
Intervention: Benazepril
Number of subjects: 0
Study: 6356323

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g twice daily)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 30506899

Group type: EXPERIMENTAL
Intervention: Decrease in evening blue light exposure (via blue-light-blocking glasses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased morning light exposure (via the use of curtains)
Number of subjects: 0
Study: 28710666

Group type: EXPERIMENTAL
Intervention: Information + action control text messages
Number of subjects: 121

Group type: COMPARATOR
Intervention: Information only (Control)
Number of subjects: 121
Study: 26658239

Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy
Number of subjects: 1294
Study: 24263388

Group type: EXPERIMENTAL
Intervention: 75‐mmHg continuous pressure with a silicone‐covered dressing
Number of subjects: 40

Group type: COMPARATOR
Intervention: 125‐mmHg with a polyurethane foam dressing
Number of subjects: 40
Study: 24015697

Group type: EXPERIMENTAL
Intervention: Green tea plus vitamin E (GTVE; 3 cups and 400 IU, respectively; n = 11)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 22
Study: 20664489

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Higher doses of olanzapine
Number of subjects: 58
Study: 18604601

Group type: EXPERIMENTAL
Intervention: Positive affective stimuli
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Beverage cue
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Negative affective stimuli
Number of subjects: 47

Group type: COMPARATOR
Intervention: Interaction effects between affect and beverage conditions
Number of subjects: 47
Study: 17172427

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg twice daily for 5 to 15 days before surgery
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Celecoxib for 28 days in xenografted mice
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 17
Study: 14517580

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate concentrations (1-100 microg/mL)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy controls (pair-matched for age, reproductive and smoking status)
Number of subjects: 19
Study: 11081318

Group type: EXPERIMENTAL
Intervention: Transdermal dihydrotestosterone (DHT) treatment for 12 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as control)
Number of subjects: 10
Study: 8721258

Group type: EXPERIMENTAL
Intervention: 50 mg riluzole
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 100 mg riluzole
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 200 mg riluzole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1416129

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia by epidural infusion of buprenorphine (3 micrograms/mL) with 0.03% bupivacaine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Patient-controlled analgesia by epidural infusion of fentanyl (2 micrograms/mL) with 0.03% bupivacaine
Number of subjects: 23
Study: 3986085

Group type: EXPERIMENTAL
Intervention: Oral secoverine hydrochloride
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30908367

Group type: COMPARATOR
Intervention: Sham + Pla
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: a‐tDCS + Pla
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sham + Caff
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: a‐tDCS + Caff
Number of subjects: 15
Study: 30396975

Group type: EXPERIMENTAL
Intervention: Rectus sheath block (RSB) analgesia - single-dose
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Rectus sheath block (RSB) analgesia - repeated-dose
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Rectus sheath block (RSB) analgesia - continuous infusion
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no RSB analgesia)
Number of subjects: 56
Study: 26969158

Group type: EXPERIMENTAL
Intervention: Hospital play interventions
Number of subjects: 304

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 304
Study: 25223547

Group type: EXPERIMENTAL
Intervention: One-day bowel preparation with Miralax®
Number of subjects: 32

Group type: COMPARATOR
Intervention: Three-day bowel preparation with Miralax®
Number of subjects: 32
Study: 22344064

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 29
Study: 20045611

Group type: EXPERIMENTAL
Intervention: Open-toed, elastic, class III compression device (Tubulcus)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Multi-component bandaging system (Tubulcus + one elastic bandage)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Multi-component bandaging system (Tubulcus + two elastic bandages)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Single-component compression system (group A)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Multi-component compression systems (groups B and C)
Number of subjects: 131
Study: 18070300

Group type: EXPERIMENTAL
Intervention: Transesophageal cardioversion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transthoracic cardioversion
Number of subjects: 60
Study: 15668847

Group type: EXPERIMENTAL
Intervention: Outpatient rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient rehabilitation
Number of subjects: 0
Study: 11007446

Group type: COMPARATOR
Intervention: placebo-8 hr time-in-bed (TIB)
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo-4 hr TIB
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo-0 hr TIB
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: diphenhydramine 50 mg-8 hr TIB
Number of subjects: 17
Study: 9076381

Group type: EXPERIMENTAL
Intervention: Antithrombin supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8436497

Group type: EXPERIMENTAL
Intervention: Trazodone (1 mg/kg a day divided into 3 doses) for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trazodone (after washout period for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (after washout period for 12 weeks)
Number of subjects: 40
Study: 3743531

Group type: EXPERIMENTAL
Intervention: Urine alarm (UA) alone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Urine alarm (UA) plus retention control training (RCT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (premature termination)
Number of subjects: 50
Study: 29278443

Group type: EXPERIMENTAL
Intervention: Solution-focused approach interview technique (8 interviews at 2-week intervals, 30-45 min each)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Solution-focused approach interview technique
Number of subjects: 32
Study: 26617254

Group type: EXPERIMENTAL
Intervention: High-intensity endurance training (70-85% of heart rate reserve; n=38)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance training (40-55% heart rate reserve; n=32)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (n=36)
Number of subjects: 106
Study: 23436863

Group type: EXPERIMENTAL
Intervention: Stereotactic core needle biopsy (CNB) or vacuum‐assisted biopsy (VAB) for DIN 1A
Number of subjects: 239

Group type: COMPARATOR
Intervention: Imaging follow-up for patients who did not undergo surgical excision
Number of subjects: 239
Study: 21631932

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18098228

Group type: EXPERIMENTAL
Intervention: Triple-negative breast cancer (FDG-PET imaging)
Number of subjects: 88

Group type: COMPARATOR
Intervention: ER+/PR+/HER2- breast cancer (FDG-PET imaging)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Triple-negative breast cancer (tumor size < or = 2 cm)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Triple-negative breast cancer (tumor size > 2 cm)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Triple-negative breast cancer (grade 3 tumors)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Triple-negative breast cancer (stage II disease)
Number of subjects: 88
Study: 16579997

Group type: EXPERIMENTAL
Intervention: CC+MET
Number of subjects: 31

Group type: COMPARATOR
Intervention: CC
Number of subjects: 31
Study: 12690917

Group type: EXPERIMENTAL
Intervention: Carbon-coated stent (Carbostent, n = 23)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Uncoated stent (Multilink, n = 21)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Carbon-coated stent (Carbostent)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Uncoated stent (Multilink)
Number of subjects: 44